E. Valoti

发表

Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.

G. Remuzzi, E. Daina, P. Iatropoulos, 2016, Molecular immunology.

Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome.

J. Atkinson, M. Noris, C. Hue, 2015, Blood.

Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant

G. Remuzzi, A. Benigni, P. Iatropoulos, 2020, Frontiers in Medicine.

Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS

G. Remuzzi, A. Benigni, A. Amoroso, 2019, Front. Immunol..

Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature.

L. Allegri, A. Vaglio, M. Noris, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes

G. Remuzzi, A. Benigni, P. Ruggenenti, 2019, Front. Genet..

Mycoplasma pneumoniae Infection Associated with Anti-Factor H Autoantibodies in Atypical Hemolytic Uremic Syndrome.

R. Donadelli, Cristina Bertulli, C. Mele, 2022, Nephron.

An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.

G. Remuzzi, A. Benigni, A. Perna, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.

G. Remuzzi, S. Rodríguez de Córdoba, M. Noris, 2015, Journal of the American Society of Nephrology : JASN.

Clinical Practice: Case Report

R. Donadelli, Cristina Bertulli, C. Mele, 2022 .

Hemolytic Uremic Syndrome in an Infant with Primary Hyperoxaluria Type II: An Unreported Clinical Association

G. Remuzzi, A. Benigni, M. Noris, 2019, Nephron.

Genetic factors associated with anti-factor H autoantibodies in atypical hemolytic uremic syndrome (aHUS)

E. Valoti, 2018 .

Two Patients With History of STEC‐HUS, Posttransplant Recurrence and Complement Gene Mutations

G. Remuzzi, F. Thaiss, C. Tripodo, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy.

Francesco Tedesco, Giuseppe Remuzzi, Piero Ruggenenti, 2014, Blood.

Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic Syndrome.

G. Remuzzi, R. Lifton, Mathieu Lemaire, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.

G. Remuzzi, S. Rodríguez de Córdoba, P. Sánchez-Corral, 2013, Journal of the American Society of Nephrology : JASN.

CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis

G. Remuzzi, A. Benigni, P. Iatropoulos, 2021, Frontiers in Genetics.

Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.

G. Remuzzi, E. Daina, P. Iatropoulos, 2017, Journal of the American Society of Nephrology : JASN.

More about Factor H Autoantibodies in Membranous Nephropathy.

G. Remuzzi, M. Noris, E. Valoti, 2019, The New England journal of medicine.